The Canadian Cancer Research Alliance

In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and clinical interventions — and includes new work streams such as: improving the appropriate prescribing and use of medications increasing pan-Canadian data collection and expanding access to drug and treatment data, including real-world evidence data reducing drug system duplicat...

The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical trial conduct! This comprehensive EDI Framework and Toolkit resource are the products of an expert working group comprised of 3CTN members, trial sponsors, and people with lived experience from underrep...

The Canadian Institutes of Health Research (CIHR) is recruiting members to join one of its 13 Institute Advisory Boards (IABs). New members will be invited to serve a first term of three years beginning on January 1, 2025. Members from all communities are encouraged to apply, especially those from Indigenous, Francophone and equity-denied communities; LGBTQ2S+ communities; and persons with disabilities. Patients, patient advocates and individuals with lived experience are also encouraged to a...

The 8th biennial Canadian Cancer Research Conference (CCRC) is scheduled for November 2–4, 2025 at the Telus Convention Centre & Hyatt Regency Hotel in Calgary, Alberta. We hope to see you there!